Large employers are bracing for a significant rise in healthcare costs, anticipating a 50% increase by 2025 compared to 2017 levels. A major contributor to this surge is expected to be prescription drug spending, particularly on GLP-1 medications. These drugs, which have garnered attention for their use in weight management and reducing cardiovascular risks, are proving costly, leading to concerns among employers.

For more details please visit our website : https://www.hroutlook.com/2024/08/27/survey-reveals-weight-loss-drugs-raise-healthcare-cost-worries-for-major-employers-in-2025/